Shirong K. Zhang

Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province, Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province Hangzhou
Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Cyclofenil blocks the secretion of IL-1β by inhibiting assembly of the NLRP3 inflammasome independent of estrogen receptor.

Cyclofenil blocks the secretion of IL-1β by inhibiting assembly of the NLRP3 inflammasome independent of estrogen receptor.

Journal: Molecular biology reports

Published: May 18, 2026

Expert consensus on the detection and clinical application of tumor mutational burden.

Expert consensus on the detection and clinical application of tumor mutational burden.

Journal: Cancer biology & medicine

Published: February 18, 2026

A Non-Canonical Role of SMAD4 in Regulating 3D Genome Architecture to Inhibit Lung Squamous Cell Carcinoma Development.

A Non-Canonical Role of SMAD4 in Regulating 3D Genome Architecture to Inhibit Lung Squamous Cell Carcinoma Development.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 25, 2025

Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation.

Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: October 16, 2025

International guidelines on the diagnosis and treatment of NUT carcinoma.

International guidelines on the diagnosis and treatment of NUT carcinoma.

Journal: Innovation (Cambridge (Mass.))

Published: April 11, 2025

Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.

Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.

Journal: Cancer biology & medicine

Published: April 09, 2025

Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors.

Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors.

Journal: Global medical genetics

Published: November 25, 2024

Corrigendum to "SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer" [Cancer Lett. 524 (2022) 268-283].

Corrigendum to "SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer" [Cancer Lett. 524 (2022) 268-283].

Journal: Cancer letters

Published: November 24, 2024

Toward the DNA methylation haplotype map of 11 common solid cancers.

Toward the DNA methylation haplotype map of 11 common solid cancers.

Journal: Cell reports

Published: November 15, 2024

UCNPs@PVP-Hemin-GOx@CaCO3 Nanoplatform for Ferroptosis Self-Amplification Combined with Calcium Overload.

UCNPs@PVP-Hemin-GOx@CaCO3 Nanoplatform for Ferroptosis Self-Amplification Combined with Calcium Overload.

Journal: Advanced healthcare materials

Published: October 28, 2024

Clinical efficacy of immune checkpoint inhibitors for cancer of unknown primary: a multi-center retrospective study.

Clinical efficacy of immune checkpoint inhibitors for cancer of unknown primary: a multi-center retrospective study.

Journal: BMC cancer

Published: October 26, 2024

Can mutation abundance assess the biological behavior of BRAFV600E-positive papillary thyroid carcinoma?

Can mutation abundance assess the biological behavior of BRAFV600E-positive papillary thyroid carcinoma?

Journal: Journal of translational medicine

Published: September 13, 2024

Showing 1-12 of 89

Last Updated: 09/26/2026